Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Development and characterization of an equine infectious anemia virus Env-pseudotyped reporter virus.

Tallmadge RL, Brindley MA, Salmans J, Mealey RH, Maury W, Carpenter S.

Clin Vaccine Immunol. 2008 Jul;15(7):1138-40. doi: 10.1128/CVI.00088-08. Epub 2008 Apr 30.

2.
4.

Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.

Tagmyer TL, Craigo JK, Cook SJ, Issel CJ, Montelaro RC.

J Gen Virol. 2007 Apr;88(Pt 4):1324-36.

PMID:
17374779
7.

Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.

Tagmyer TL, Craigo JK, Cook SJ, Even DL, Issel CJ, Montelaro RC.

J Virol. 2008 Apr;82(8):4052-63. doi: 10.1128/JVI.02028-07. Epub 2008 Jan 30.

9.
10.

Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection.

Rwambo PM, Issel CJ, Adams WV Jr, Hussain KA, Miller M, Montelaro RC.

Arch Virol. 1990;111(3-4):199-212.

PMID:
2162160
11.

Envelope determinants of equine lentiviral vaccine protection.

Craigo JK, Ezzelarab C, Cook SJ, Chong L, Horohov D, Issel CJ, Montelaro RC.

PLoS One. 2013 Jun 13;8(6):e66093. doi: 10.1371/journal.pone.0066093. Print 2013.

12.

Control of equine infectious anemia virus is not dependent on ADCC mediating antibodies.

Tschetter JR, Byrne KM, Perryman LE, McGuire TC.

Virology. 1997 Apr 14;230(2):275-80.

13.

An EIAV field isolate reveals much higher levels of subtype variability than currently reported for the equine lentivirus family.

Craigo JK, Barnes S, Zhang B, Cook SJ, Howe L, Issel CJ, Montelaro RC.

Retrovirology. 2009 Oct 20;6:95. doi: 10.1186/1742-4690-6-95.

14.

Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus.

Hammond SA, Li F, McKeon BM Sr, Cook SJ, Issel CJ, Montelaro RC.

J Virol. 2000 Jul;74(13):5968-81.

15.

A pilot study comparing the development of EIAV Env-specific antibodies induced by DNA/recombinant vaccinia-vectored vaccines and an attenuated Chinese EIAV vaccine.

Meng Q, Lin Y, Ma J, Ma Y, Zhao L, Li S, Yang K, Zhou J, Shen R, Zhang X, Shao Y.

Viral Immunol. 2012 Dec;25(6):477-84. doi: 10.1089/vim.2012.0014. Epub 2012 Nov 21.

16.
17.

Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection.

Salinovich O, Payne SL, Montelaro RC, Hussain KA, Issel CJ, Schnorr KL.

J Virol. 1986 Jan;57(1):71-80.

18.

Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus.

Issel CJ, Horohov DW, Lea DF, Adams WV Jr, Hagius SD, McManus JM, Allison AC, Montelaro RC.

J Virol. 1992 Jun;66(6):3398-408.

20.

Protective efficacy of centralized and polyvalent envelope immunogens in an attenuated equine lentivirus vaccine.

Craigo JK, Ezzelarab C, Cook SJ, Liu C, Horohov D, Issel CJ, Montelaro RC.

PLoS Pathog. 2015 Jan 8;11(1):e1004610. doi: 10.1371/journal.ppat.1004610. eCollection 2015 Jan.

Items per page

Supplemental Content

Write to the Help Desk